|
1.
|
原著(症例報告除く)
|
Pretransplantation predictors of survival in nonremission acute myeloid leukemia treated with haploidentical transplantation using steroid-based GVHD prophylaxis 2024/04
|
|
2.
|
症例報告
|
Successful treatment of Dara sc-CyBorD in a patient with AL amiyloidosis and severe heart failure 2024/02
|
|
3.
|
原著(症例報告除く)
|
Long-term Use of Ibrutinib in Japanese Patients with Steroid Dependent/Refractory cGVHD: Final Analysis of Multicenter Study 2023/11
|
|
4.
|
原著(症例報告除く)
|
Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study 2023/05
|
|
5.
|
原著(症例報告除く)
|
Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation 2023
|
|
6.
|
原著(症例報告除く)
|
1. Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation. 2022/08
|
|
7.
|
原著(症例報告除く)
|
Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma. 2021/12
|
|
8.
|
症例報告
|
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone. 2021/12
|
|
9.
|
原著(症例報告除く)
|
Open-Label, Single-Arm, Multicenter Study of Ibrutinib in Japanese Patients With Steroid-dependent/Refractory Chronic Graft-Versus-Host Disease. 2021/10
|
|
10.
|
原著(症例報告除く)
|
Treatment of intestinal graft-versus-host disease using betamethasone enemas. 2021/10
|
|
11.
|
原著(症例報告除く)
|
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. 2021/08
|
|
12.
|
原著(症例報告除く)
|
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia 2021/06
|
|
13.
|
原著(症例報告除く)
|
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin. 2021/03
|
|
14.
|
原著(症例報告除く)
|
Hematopoietic stem cell transplantation for diffuse large B-cell lymphoma having 8q24/MYC rearrangement in Japan. 2021/02
|
|
15.
|
原著(症例報告除く)
|
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study. 2021/01
|
|
16.
|
総説
|
.本態性血小板血症と出血症状 32巻4号 389-392. 2021 2021
|
|
17.
|
症例報告
|
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion. 2020/06
|
|
18.
|
原著(症例報告除く)
|
DADI Trial Group. Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial. 2020/03
|
|
19.
|
原著(症例報告除く)
|
Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP. 2019/09
|
|
20.
|
原著(症例報告除く)
|
11. Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. 2019/07
|
|
21.
|
原著(症例報告除く)
|
12. Early evaluation of tumor response to 90Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT? 2019/07
|
|
22.
|
原著(症例報告除く)
|
Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
|
|
23.
|
原著(症例報告除く)
|
DADI Trial Group, Japan. Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment. 2018/05
|
|
24.
|
原著(症例報告除く)
|
A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. 2018/04
|
|
25.
|
総説
|
【移植片対宿主病(GVHD)-病態解明と治療法の進歩-】移植片対宿主病(GVHD)の診断と治療法の進歩 移植片対宿主病(GVHD)に対する間葉系幹細胞(MSC)の臨床応用 2018
|
|
26.
|
総説
|
【間葉系幹細胞移植のupdate】羊膜由来間葉系幹細胞による急性GVHD治療 2018
|
|
27.
|
症例報告
|
Spousal hematopoietic stem cell transplantation. 2017/05
|
|
28.
|
原著(症例報告除く)
|
DADI Trial Group..Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. 2016/11
|
|
29.
|
原著(症例報告除く)
|
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. 2016/03
|
|
30.
|
症例報告
|
Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity. 2016/02
|
|
31.
|
原著(症例報告除く)
|
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. 2016/02
|
|
32.
|
原著(症例報告除く)
|
Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood. 2016/01
|
|
33.
|
原著(症例報告除く)
|
Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation 2016/01
|
|
34.
|
総説
|
【同種造血幹細胞移植の多様性:細胞ソースと血縁・非血縁】 血縁者間HLAハプロ一致移植 低用量ATG+steroidを用いた血縁者間HLAハプロ一致移植 2016
|
|
35.
|
総説
|
【日常診療で遭遇する難治性造血器腫瘍の話題とそのアプローチ】 移植後再発例への治療戦略 2016
|
|
36.
|
総説
|
【白血病学(下)-最新の基礎、臨床研究-】 白血病の治療 総論 造血幹細胞移植(理論、方法) 同種造血幹細胞移植 HLA半合致移植 2016
|
|
37.
|
症例報告
|
Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab. 2015/11
|
|
38.
|
原著(症例報告除く)
|
Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. 2015/10
|
|
39.
|
原著(症例報告除く)
|
Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan. 2015/08
|
|
40.
|
原著(症例報告除く)
|
A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia. 2015/02
|
|
41.
|
症例報告
|
Primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type with malakoplakia in the urinary bladder: a case report. 2014/07
|
|
42.
|
症例報告
|
Primary follicular lymphoma of the spleen incidentally found in a patient with alcohol- and hepatitis C-related liver cirrhosis. 2014/06
|
|
43.
|
原著(症例報告除く)
|
Recombinant human soluble thrombomodulin attenuates FK506-induced endothelial dysfunction through prevention of Akt inactivation. 2014/04
|
|
44.
|
原著(症例報告除く)
|
Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning. 2014/04
|
|
45.
|
原著(症例報告除く)
|
Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts. 2014/02
|
|
46.
|
原著(症例報告除く)
|
Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: possible association with nelarabine. 2013/10
|
|
47.
|
原著(症例報告除く)
|
Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97. 2013/10
|
|
48.
|
原著(症例報告除く)
|
Double-unit cord blood transplantation after myeloablative conditioning for patients with hematologic malignancies: a multicenter phase II study in Japan. 2013/05
|
|
49.
|
原著(症例報告除く)
|
FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. 2013/04
|
|
50.
|
症例報告
|
Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation. 2013/02
|
|
51.
|
症例報告
|
Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation. 2012/12
|
|
52.
|
原著(症例報告除く)
|
Haploidentical hematopoietic stem cell transplantation for lymphoma with monosomy of chromosome 6 (loss of heterozygosity in the HLA region) — Who should be a donor? 2012/12
|
|
53.
|
原著(症例報告除く)
|
Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy. 2012/12
|
|
54.
|
原著(症例報告除く)
|
Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. 2012/12
|
|
55.
|
原著(症例報告除く)
|
Long-term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia. 2012/11
|
|
56.
|
原著(症例報告除く)
|
Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study 2012/08
|
|
57.
|
原著(症例報告除く)
|
Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation. 2012/08
|
|
58.
|
原著(症例報告除く)
|
Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients. 2012/07
|
|
59.
|
原著(症例報告除く)
|
Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. 2012/04
|
|
60.
|
原著(症例報告除く)
|
Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study. 2012/04
|
|
61.
|
原著(症例報告除く)
|
Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning. 2012/03
|
|
62.
|
原著(症例報告除く)
|
Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria. 2011/10
|
|
63.
|
原著(症例報告除く)
|
Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis. 2011/06
|
|
64.
|
症例報告
|
Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation. 2011/04
|
|
65.
|
症例報告
|
Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan. 2011/04
|
|
66.
|
症例報告
|
Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene. 2011/02
|
|
67.
|
症例報告
|
Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia. 2010/10
|
|
68.
|
原著(症例報告除く)
|
Diffuse large B-cell lymphoma in the spinal epidural space: A study of the Osaka Lymphoma Study Group. 2010/07
|
|
69.
|
原著(症例報告除く)
|
Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan. 2010/07
|
|
70.
|
原著(症例報告除く)
|
Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells. 2010/04
|
|
71.
|
原著(症例報告除く)
|
Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study. 2010/03
|
|
72.
|
原著(症例報告除く)
|
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL. 2009/06
|
|
73.
|
原著(症例報告除く)
|
Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. 2009/04
|
|
74.
|
原著(症例報告除く)
|
Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1,072 patients in Japan. 2008/09
|
|
75.
|
原著(症例報告除く)
|
Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. 2008/08
|
|
76.
|
原著(症例報告除く)
|
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. 2007/07
|
|
77.
|
原著(症例報告除く)
|
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates. 2007/07
|
|
78.
|
原著(症例報告除く)
|
Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome. 2007/03
|
|
79.
|
原著(症例報告除く)
|
Serum elastase and antithrombin-3 levels after umbilical cord blood transplantation or bone marrow transplantation. 2007/02
|
|
80.
|
原著(症例報告除く)
|
Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation. 2006/10
|
|
81.
|
原著(症例報告除く)
|
Changes of clotting factors (7, 9 and 10) and hepatocyte growth factor in patients with thrombotic microangiopathy after bone marrow transplantation. 2006/09
|
|
82.
|
原著(症例報告除く)
|
Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation. 2006/04
|
|
83.
|
原著(症例報告除く)
|
Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. 2006/01
|
|
84.
|
原著(症例報告除く)
|
Serum elastase and antithrombin-3 in patients with acute graft-vs.-host disease after bone marrow transplantation. 2005/08
|
|
85.
|
原著(症例報告除く)
|
Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation. 2005/06
|
|
86.
|
原著(症例報告除く)
|
Relationships between hematological recovery and overall survival in older adults undergoing allogeneic bone marrow transplantation. 2005/01
|
|
87.
|
原著(症例報告除く)
|
Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation. 2004/10
|
|
88.
|
原著(症例報告除く)
|
Idiopathic interstitial pneumonia following stem cell transplantation. 2003/08
|
|
89.
|
原著(症例報告除く)
|
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation. 2003/05
|
|
90.
|
原著(症例報告除く)
|
Endothelial damage caused by cytomegalovirus and human herpesvirus-6. 2003/03
|
|
91.
|
原著(症例報告除く)
|
Influence of Helicobacter pylori on platelets after bone marrow transplantation from unrelated donors. 2003/03
|
|
92.
|
原著(症例報告除く)
|
Effect of eicosapentaenoic acid in patients with refractory myelodysplastic syndrome. 2002/12
|
|
93.
|
原著(症例報告除く)
|
Effects of total body irradiation on the vascular endothelium. 2002/10
|
|
94.
|
原著(症例報告除く)
|
Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis. 2002/10
|
|
95.
|
症例報告
|
Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case report. 2002/06
|
|
96.
|
原著(症例報告除く)
|
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation. 2002/06
|
|
97.
|
症例報告
|
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16. 2002/01
|
|
98.
|
原著(症例報告除く)
|
Oral eicosapentaenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation. 2002
|
|
99.
|
原著(症例報告除く)
|
Relationship between immunological abnormalities and paroxysmal nocturnal haemoglobinuria-associated clones in myelodysplastic syndromes. 2001/09
|
|
100.
|
症例報告
|
Changes of cytokines during the course of graft-versus-host disease following bone marrow transplantation: a case report. 2000/08
|
|
101.
|
原著(症例報告除く)
|
Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship. 2000/07
|
|
102.
|
原著(症例報告除く)
|
The role of screening bronchoalveolar lavage in BMT patients. 2000/06
|
|
103.
|
原著(症例報告除く)
|
Association of cytomegalovirus interstitial pneumonitis with HLA-type following allogeneic bone marrow transplantation. 2000/04
|
|
104.
|
原著(症例報告除く)
|
Changes in microbial flora in neutropenic patients with hematological disorders after the Hanshin-Awaji earthquake. 2000/04
|
|
105.
|
原著(症例報告除く)
|
Good response to cyclosporine therapy in patients with myelodysplastic syndromes having the HLA-DRB1*1501 allele. 2000/02
|
|
106.
|
症例報告
|
Acute pomyelocytic leukemia with marrow fibrosis at initial presentation: possible involvement of transforming growth factor-beta(1). 2000
|
|
107.
|
原著(症例報告除く)
|
Function and X chromosome inactivation analysis of B lymphocytes in myelodysplastic syndromes with immunological abnormalities. 2000
|
|
108.
|
原著(症例報告除く)
|
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma. 2000
|
|
109.
|
症例報告
|
New imaging findings in a patient with central nervous system dysfunction after bone marrow transplantation. 2000
|
|
110.
|
原著(症例報告除く)
|
Adult respiratory distress syndrome-like disorders after allogeneic bone marrow transplantation. 1999/11
|
|
111.
|
原著(症例報告除く)
|
Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation. 1999/11
|
|
112.
|
原著(症例報告除く)
|
High-dose therapy combined with peripheral blood stem cell transplantation for advanced low-grade follicular lymphoma: single-institution experience in Japan.. 1999/10
|
|
113.
|
原著(症例報告除く)
|
Thrombotic microangiopathy following allogeneic bone marrow transplantation. 1999/08
|
|
114.
|
原著(症例報告除く)
|
Flow-cytometric analysis of leukocyte alkaline phosphatase in myelodysplastic syndromes. 1999
|
|
115.
|
原著(症例報告除く)
|
Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy. 1999
|
|
116.
|
症例報告
|
Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation. 1999
|
|
117.
|
原著(症例報告除く)
|
Clonal analysis of hematopoietic cells using a novel polymorphic site of the X chromosome. 1998/08
|
|
118.
|
症例報告
|
Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation. 1998/07
|
|
119.
|
原著(症例報告除く)
|
Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis. 1998/06
|
|
120.
|
原著(症例報告除く)
|
Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation. 1998/02
|
|
121.
|
原著(症例報告除く)
|
Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient. 1997/11
|
|
122.
|
原著(症例報告除く)
|
Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. 1997/10
|
|
123.
|
原著(症例報告除く)
|
Glutathione S-transferase theta 1 gene (GSTT1) defect in Japanese patients with myelodysplastic syndromes. 1997/10
|
|
124.
|
原著(症例報告除く)
|
Detection of donor-type alveolar macrophages in transplantation with highly purified CD34+ bone marrow cells. 1997/07
|
|
125.
|
原著(症例報告除く)
|
Second transplantation with CD34+ bone marrow cells selected from a two-loci HLA-mismatched sibling for a patient with chronic myeloid leukaemia. 1996/07
|
|
126.
|
原著(症例報告除く)
|
Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation. 1996/02
|
|
127.
|
総説
|
骨髄移植後の合併症とその対策 出血性膀胱炎の予防,診断,治療 1995
|
|
5件表示
|
|
全件表示(127件)
|
教員情報
